References
- Abraham TM, Pencina KM, Pencina MJ, Fox CS. Trends in diabetes incidence: the Framingham heart study. Diab Care 38, 482–487, 2015.10.2337/dc14-1432
- Addai D, Zarkos J, Tolekova A. The bone hormones and their potential effects on glucose and energy metabolism. 53, 268–273, 2019.10.2478/enr-2019-0027
- Aikin R, Rosenberg L, Paraskevas S, Maysinger D. Inhibition of caspase-mediated PARP-1 cleavage results in increased necrosis in isolated islets of Langerhans. J Mol Med (Berl) 82, 389–397, 2004.10.1007/s00109-004-0540-5
- Ansley DM, Wang B. Oxidative stress and myocardial injury in the diabetic heart. J Pathol 229, 232–241, 2012.10.1002/path.4113
- Benjamin ML, Thomas MM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes 6, 1246–1258, 2015.10.4239/wjd.v6.i13.1246
- Bergmeyer H. Methods of Enzymatic Analysis. Verlag Chemie, New York, London, 1974.
- Berridge MJ. Vitamin D cell signalling in health and disease. Biochem Biophys Res Commun. 460, 53–71, 2015.10.1016/j.bbrc.2015.01.008
- Berridge MJ. Vitamin D and depression: cellular and regulatory mechanisms. Pharmacol Rev 69, 80–92, 2017.10.1124/pr.116.013227
- Blenn C, Wyrsch P, Bader J, Bollhalder M, Althaus FR. Poly(ADP-ribose)glycohydrolase is an upstream regulator of Ca2+ fluxes in oxidative cell death. Cell Mol Life Sci 68, 1455–1466, 2011.10.1007/s00018-010-0533-1
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248–254, 1976.10.1016/0003-2697(76)90527-3
- Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 96, 365–408, 2016.10.1152/physrev.00014.2015483949326681795
- Chiarugi A, Dolle C, Felici R, Ziegler M. The NAD metabolome - a key determinant of cancer cell biology. Nat Rev Cancer 12, 741–752, 2012.10.1038/nrc3340
- van Diepen JA, Thiem K, Stienstra R, Riksen NP, Tack CJ, Netea MG. Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive. Cell Mol Life Sci 73, 4675–4684, 2016.10.1007/s00018-016-2316-9
- Dillmann WH. Diabetic Cardiomyopathy. Circ Res 124, 1160–1162, 2019.10.1161/CIRCRESAHA.118.314665
- DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet 391, 2449–2462, 2018.10.1016/S0140-6736(18)31320-5
- Du L, Zhang X, Han YY, Burke NA, Kochanek PM, Watkins SC, Graham SH, Carcillo JA, Szabo C, and Clark RSB. Intra-mitrochondrial poly (ADP-ribosylation) contributes to NAD depletion and cell death induced by oxidative stress. J Biol Chem 278, 18426–18433, 2003.10.1074/jbc.M30129520012626504
- Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, Mathiesen EB, Njolstad I, Lochen ML, Marz W et al. Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One 12, e0170791, 2017.10.1371/journal.pone.0170791531292628207791
- Giwa AM, Ahmed R, Omidian Z, Majety N, Karakus KE, Omer SM, Donner T, Hamad ARA. Current understandings of the pathogenesis of type 1 diabetes: Genetics to environment. World J Diabetes 11, 13–25, 2020.10.4239/wjd.v11.i1.13692781931938470
- Guzyk MM, Tykhomyrov AA, Nedzvetsky VS, Prischepa IV, Grinenko TV, Kuchmerovska TM. Poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors reduce reactive gliosis and improve angiostatin levels in retina of diabetic rats. Neurochem Res 41, 2526–2537, 2016.10.1007/s11064-016-1964-327255598
- Guzyk MM, Dyakun KO, Yanytska LV, Pryvrotska I B, Krynytska IY, Pishel IM, Kuchmerovska TM. Inhibitors of poly(ADP-Ribose)polymerase-1 as agents providing correction of brain dysfunctions induced by experimental diabetes. Neurophysiology 49, 183–193, 2017.10.1007/s11062-017-9672-4
- Guzyk MM, Tykhonenko TM, Dyakun KO, Yanitska LV, Pryvrotska IB, Kuchmerovska TM. Altered sirtuins 1 and 2 expression in the brain of rats induced by experimental diabetes and the ways of its correction. Ukr Biochem J 91, 21–29, 2019.10.15407/ubj91.01.021
- Heid CA, Stevens J, Livak KJ, PM Williams PM. Real time quantitative pcr. Genome Research 6, 986–994, 1996.10.1101/gr.6.10.9868908518
- Homburg S, Visochek L, Moran N, Dantzer F, Priel E, Asculai E, Schwartz D, Rotter V, Dekel N, Cohen-Armon M. A fast signal induced activation of poly (ADP) ribose polymerase: a novel downstream target of phospholipase-C. J Cell Biol 150, 293–307, 2000.10.1083/jcb.150.2.293218022710908573
- Houtkooper RH, Canto C, Wanders RJ, Auwerx J. The secret life of NAD+: An old metabolite controlling new metabolic signaling pathways. Endocr Rev 31, 194–223, 2010.10.1210/er.2009-0026285220920007326
- Kasatkina LA, Tarasenko AS, Krupko OO, Kuchmerovska TM, Lisakovska OO, Trikash IO. Vitamin D deficiency induces the excitation/inhibition brain imbalance and the proinflammatory shift. Int J Biochem Cell Biol 119, 105665, 2020.10.1016/j.biocel.2019.10566531821883
- Katsyuba E, Auwerx J. Modulating NAD (+) metabolism, from bench to bedside. EMBO J 36, 2670–2683, 2017.10.15252/embj.201797135559980128784597
- Kraus WL, Hottiger MO. PARP-1 and gene regulation: Progress and puzzles. Molecular Aspects of Medicine 34, 1109–1123, 2013.10.1016/j.mam.2013.01.00523357755
- Labudzynskyi DO, Manoylov KU, Shymanskyy IO, Veliky MM. Immunoregulatory effects of vitamin D3 in experimentally induced type 1 diabetes. Cytol Genet 50, 231–240, 2016.10.3103/S0095452716040071
- Lee CF, Chavez JD, Garcia-Menendez L, Choi Y, Roe ND, Chiao YA, Edgar JS, Goo YA, Goodlett DR et al. Normalization of NAD+ Redox Balance as a Therapy for Heart Failure. Circulation 134, 883–894, 2016.10.1161/CIRCULATIONAHA.116.022495519313327489254
- Li W, Zhao W, Wu Q, Lu Y, Shi J, Chen X. Puerarin improves diabetic aorta injury by inhibiting NADPH oxidase-derived oxidative stress in STZ-induced diabetic rats. J Diabetes Res 2016, 8541520, 2016.10.1155/2016/8541520473680926881260
- Lorenzo-Almoros A, Tunon J, Orejas M, Cortes M, Egido J, Lorenzo O. Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol 16, 28, 2017.10.1186/s12933-017-0506-x532426228231848
- Mandavia CH, Aroor AR, Demarco VG, Sowers JR. Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. Life Sci 92, 601–608, 2013.10.1016/j.lfs.2012.10.028359413523147391
- Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev 18, 149–66, 2013.10.1007/s10741-012-9313-3359300922453289
- Nakajima H, Kubo T, Ihara H, Hikida T, Danjo T, Nakatsuji M, Shahani N, Itakura M, Ono Y, Azuma YT, Inui T, Kamiya A, Sawa A, Takeuchi T. Nuclear-translocated glyceraldehyde-3-phosphate dehydrogenase promotes poly(ADP-ribose) polymerase-1 activation during oxidative/nitrosative stress in stroke. J Biol Chem 290, 14493–14503, 2015.10.1074/jbc.M114.635607450551725882840
- Nakaoka K, Yamada A, Noda S, Goseki-Sone M. Vitamin D-restricted high-fat diet down-regulates expression of intestinal alkaline phosphatase isozymes in ovariectomized rats. Nutr Res 53, 23–31, 2018.10.1016/j.nutres.2018.03.00129804586
- Okabe K, Yaku K, Tobe K, Nakagawa T. Implications of altered NAD metabolism in metabolic disorders. J Biomed Sci 26, 34, 2019.10.1186/s12929-019-0527-8651166231078136
- Pallayova M, Breznoscakova D. The altered circadian pattern of basal insulin requirements – an early marker of autoimmune polyendocrine syndromes in type 1 diabetes mellitus. Endocr Regul 54, 126–132, 2020.10.2478/enr-2020-001532597157
- Pike JW, Meyer MB, Lee SM, Onal M, Benkusky NA. The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights J Clin Invest 127, 1146–1154, 2017.10.1172/JCI88887537385328240603
- Pillai JB, Russell HM, Raman J, Jeevanandam V, Gupta MP. Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure. Am J Physiol Heart Circ Physiol 288, 486–496, 2005.10.1152/ajpheart.00437.200415374823
- Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, Genuth S, Grimm RH, Corson MA, Prineas R; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 33, 1578–1584, 2010.10.2337/dc10-0125289036220215456
- Rodriguez MI, Gonzalez-Flores A, Dantzer F, Collard J, Herreros AG, Oliver FJ. Poly(ADP-ribose)-dependent regulation of Snail1 protein stability. Oncogene 30, 4365–4372, 2011.10.1038/onc.2011.15321577210
- Sarwar N, Gao P, Kondapally Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375, 2215–22, 2010.10.1016/S0140-6736(10)60484-9
- Schumann G, Klauke R, Canalias F, Bossert-Reuther S, Franck PFH, Gella FJ, Jorgensen PJ, Kang D, Lessinger JM, Panteghini M, Ceriotti F. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 9: reference procedure for the measurement of catalytic concentration of alkaline phosphatase. Clin Chem Lab Med 49, 1439–1446, 2011.10.1515/CCLM.2011.62121702699
- Seibel MJ. Biochemical Markers of bone turnover Part I: Biochemical and variability. Clin Biochem Rev 26, 97–122, 2005.10.1007/978-1-59745-459-9_5
- Garcia Soriano F, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, Southan GJ, Szabo C. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 7, 108–113, 2001.10.1038/8324111135624
- Taimeh Z, Loughran J, Birks EJ, Bolli R. Vascular endothelial growth factor in heart failure. Nat Rev Cardiol 10, 519–530, 2013.10.1038/nrcardio.2013.9423856679
- Tziakas DN, Chalikias GK, Kaski JC. Epidemiology of the diabetic heart. Coron Artery Dis 16 Suppl 1, S3–S10, 2005.10.1097/00019501-200511001-0000216340402
- Varga ZV, Giricz Z, Liaudet L, Hasko G, Ferdinandy P, Pacher P. Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim Biophys Acta 1852, 232–242, 2015.10.1016/j.bbadis.2014.06.030427789624997452
- Vincent AM, Perrone L, Sullivan KA, Backus C, Sastry AM, Lastoskie C, Feldman EL. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148, 548–558, 2007.10.1210/en.2006-007317095586
- Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 26, 1553–1579, 2003.10.2337/diacare.26.5.155312716821